Screening Platform Development

Screening Platform Development is the systematic creation and refinement of integrated hardware, software, and procedural infrastructures that enable high-throughput screening processes by standardizing assay design, automation, data acquisition, and analysis workflows within biological and chemical research contexts.

214

Publications

10.6K

Citations

1.6K

Authors

492

Institutions

Publications per year

2017–2026

103

Authors

1.6K

  1. NS
    Nadi Ströhlein

    Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

    3 publications · 427 citations

    3

    h-index

  2. TR
    Tobias Richter

    University of Copenhagen, Denmark

    3 publications · 427 citations

    3

    h-index

  3. RM
    Ricardo Macarrón

    GlaxoSmithKline (United States), United States

    3 publications · 130 citations

    3

    h-index

  4. CS
    Christian Schmitt-Engel

    Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

    3 publications · 427 citations

    3

    h-index

  5. UM
    Upalparna Majumdar

    Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

    3 publications · 427 citations

    3

    h-index

1–5 of 1.6K

Venues

  1. SLAS DISCOVERY

    10 publications · 247 citations

    10

    h-index

  2. Analytical Chemistry

    7 publications · 205 citations

    7

    h-index

  3. Proceedings of the National Academy of Sciences

    PNAS · 6 publications · 583 citations

    6

    h-index

  4. Nature Communications

    6 publications · 1.3K citations

    6

    h-index

  5. Scientific Reports

    6 publications · 247 citations

    6

    h-index

1–5